Read More Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on Evofem Biosciences, Lowers Price Target to $1 By Benzinga Newsdesk August 12, 7:54 AM Morgan Stanley analyst Jeffrey Hung maintains Evofem Biosciences (NASDAQ:EVFM) with a Equal-Weight and lowers the price target from $3 to $1. EVFM
Read More News ‘Genesys Aerosystems Receives EASA Certification Approval For HeliSAS Autopilot For Bell 505 Helicopter’ – Moog By Benzinga Newsdesk September 12, 11:30 AM https://www.moog.com/news/operating-group-news/2022/genesys-aerosystems-receives-easa-cert-approval-for-helisas-autopilot-bell505-helicopter.html Mineral Wells, TX (Sept 12, 2022) – Genesys MOG/A
Read More News Offerings Tenax Therapeutics Announces Pricing Of ~$15.6M Public Offering By Happy Mohamed February 3, 9:21 AM Tenax Therapeutics, Inc. (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high TENX
Read More Global News Satellite Image Firm Maxar Says New Imagery Shows Russian Military Units Continuing To Deploy Closer To Kyiv, Firing Artillery Toward Residential Areas By Bill Haddad March 11, 6:00 PM -Reuters RSX